From the *Department of Dermatology, Massachusetts General Hospital, Harvard School of Medicine, Boston; †Department of Dermatology, University of Pennsylvania, Philadelphia; ‡University Hospitals Case Medical Center, Cleveland, OH; §Department of Dermatology, Brigham and Women’s Hospital, Harvard School of Medicine, Boston, MA; ∥Duke Dermatology, Duke University Medical Center, Durham, NC; ¶Department of Dermatology, Geisinger Health System, Danville, PA; #Department of Dermatology, George Washington University, Washington, DC; **Yale University School of Medicine, New Haven, CT; ††Division of Dermatology, McGill University Health Centre, Montréal, Quebec, Canada; ‡‡Division of Dermatology, UMass Memorial Medical Center, Worcester; §§University of Illinois at Chicago; ∥∥Division of Dermatology, Departments of Medicine and Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada; ¶¶Department of Dermatology, Stanford University, Palo Alto, CA; ##Department of Dermatology, University of Utah, Salt Lake City; ***Dermatology-Plastic Surgery Institute, Cleveland Clinic, OH; and †††Department of Medicine (Dermatology), University of Toronto, Ontario, Canada.
Address reprint requests to Peter C. Schalock, MD, Department of Dermatology, Massachusetts General Hospital, BAR622, 55 Fruit St, Boston, MA 02114. E-mail: [email protected].
The authors have no funding or conflicts of interest to declare.